Drug Type Autologous CAR-T |
Synonyms- |
Target |
Action antagonists |
Mechanism CXCR5 antagonists(C-X-C motif chemokine receptor 5 antagonists), EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists), Gene transference + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Phase 1 | China | - | |
Non-Small Cell Lung Cancer | Phase 1 | China | - |